Both companies are active in the global aesthetic market, with IRIDEX’ specialty in vascular treatments. The combination is expected to improve Cutera’s presence among primary care physicians. The transaction has been approved by both board of directors and is expected to close early this year.
Related Articles on Supply Chain:
Idaho’s Parkway Surgery Center Makes Significant Investment in New Equipment
FDA Bans Oridion Systems From Importing Medical Devices Into the U.S.
Massachusetts Life Sciences Center Awards $2.2M in Loans to Medical Technology Startups
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
